Melioidosis - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Melioidosis – Complete Medical Guide

Overview

Melioidosis is an infectious disease caused by the Gram‑negative bacterium Burkholderia pseudomallei. The organism lives in soil and surface water in tropical and subtropical regions. Humans become infected when the bacteria enter the body through skin abrasions, inhalation, or ingestion. The disease is sometimes called “the great mimicker” because its symptoms can resemble pneumonia, tuberculosis, skin infections, or even sepsis.

Melioidosis predominantly affects people living in, or who have traveled to, Southeast Asia and northern Australia. In 2022 the World Health Organization (WHO) estimated more than 165,000 cases worldwide each year, with an overall case‑fatality rate of 10‑40 % depending on the severity and the speed of treatment.1

While anyone can contract the infection, the disease is most common in adults aged 30‑60 years who have occupational or lifestyle exposure to wet soil (e.g., rice farmers, construction workers, military personnel). The incidence spikes during the rainy season, when the bacteria are displaced to the surface of the ground.

Symptoms

Melioidosis can present as a localized infection, a chronic disease, or a rapidly progressive septicemia. The following list groups symptoms by organ system and typical patterns.

General / Systemic

  • Fever (often high‑grade and intermittent)
  • Chills and rigors
  • Extreme fatigue or malaise
  • Weight loss
  • Headache

Respiratory

  • Cough (dry or productive)
  • Chest pain, especially pleuritic
  • Shortness of breath
  • Hemoptysis (coughing up blood) in severe cases
  • Radiographic signs: infiltrates, cavities, or pleural effusion

Skin and Soft Tissue

  • Localized skin ulcer or abscess
  • Swelling, erythema, and pain at the entry site
  • Subcutaneous nodules (may become pustular)
  • Necrotizing cellulitis (rare but severe)

Neurological

  • Encephalitis‑like picture: confusion, seizures, or focal deficits
  • Meningitis (rare) – neck stiffness, photophobia

Gastrointestinal / Hepatobiliary

  • Abdominal pain
  • Nausea / vomiting
  • Diarrhea (may be watery or bloody)
  • Liver or spleen enlargement (hepatosplenomegaly) on exam or imaging

Genitourinary

  • Kidney involvement – flank pain, hematuria
  • Prostatic abscess (in men)

Because the presentation is so variable, clinicians rely on a high index of suspicion, especially in endemic areas or after recent exposure to wet soils.

Causes and Risk Factors

What causes melioidosis?

The disease is caused exclusively by Burkholderia pseudomallei. The bacterium is an environmental saprophyte that survives for years in moist soil and water. Human infection occurs when viable organisms bypass the skin’s protective barrier or are inhaled/ingested.

Key risk factors

  • Occupational exposure: rice farming, fishing, construction, military training, and gardening in endemic regions.
  • Environmental exposure: walking barefoot, wading through floodwaters, or cleaning contaminated equipment.
  • Chronic medical conditions:
    • Diabetes mellitus – the single strongest host factor (up to 50 % of cases).
    • Chronic kidney disease, chronic lung disease, or liver cirrhosis.
    • Immunosuppression (e.g., corticosteroids, chemotherapy, HIV).
  • Age: Adults 30‑60 years old; children can be infected but usually have milder disease.
  • Seasonality: Heavy rains and flooding increase bacterial load on the surface, raising exposure risk.

Diagnosis

Accurate diagnosis hinges on laboratory identification of the organism and correlation with clinical findings.

Laboratory Tests

  1. Blood cultures – Positive in up to 80 % of septicemic cases. Growth may take 48‑72 hours; specialized media (e.g., Ashdown’s agar) improve detection.
  2. Culture of pus, sputum, urine, or cerebrospinal fluid – Direct sampling from the infected site is preferred when feasible.
  3. Serology – Indirect hemagglutination assay (IHA) can detect antibodies, but cross‑reactivity limits its use for acute diagnosis.
  4. Polymerase chain reaction (PCR) – Rapid detection of bacterial DNA; increasingly available in reference laboratories.

Imaging

  • Chest X‑ray/CT – Identifies pneumonia, cavities, or pleural effusions.
  • Abdominal ultrasound or CT – Detects liver/spleen abscesses, which are classic for disseminated disease.
  • MRI of the brain – Reserved for patients with neurological signs.

Diagnostic Criteria (CDC recommendation)

A confirmed case requires isolation of B. pseudomallei from a normally sterile site (blood, CSF, or tissue). Probable cases may be based on compatible clinical syndrome plus a positive serology or PCR in the context of exposure.

Treatment Options

Effective therapy involves two distinct phases: an intensive “initial” phase to eradicate active infection, followed by a prolonged “eradication” phase to prevent relapse.

Initial (Intensive) Phase – 10‑14 days

  • Ceftazidime 2 g IV every 6 hours (standard first‑line drug).
  • Alternative: Meropenem 1 g IV every 8 hours for severe sepsis, meningitis, or penicillin‑allergic patients.
  • Adjunctive trimethoprim‑sulfamethoxazole (TMP‑SMX) is sometimes added for deep‑seated infections.

Eradication (Oral) Phase – 3‑6 months

  • Trimethoprim‑sulfamethoxazole (TMP 160 mg / SMX 800 mg) PO twice daily is the backbone.
  • In patients intolerant to TMP‑SMX, a combination of doxycycline (100 mg PO twice daily) plus amoxicillin‑clavulanate (875/125 mg PO three times daily) may be used.

Special Situations

  • Pregnancy – Use of ceftazidime in the intensive phase is safe; avoid TMP‑SMX in the eradication phase.
  • Renal or hepatic impairment – Dose adjustments are required; therapeutic drug monitoring is recommended for TMP‑SMX.
  • Surgical intervention – Drainage of abscesses, debridement of necrotic tissue, or pleural drainage when indicated.

Supportive Care

Fluid resuscitation, vasopressors for septic shock, mechanical ventilation for respiratory failure, and renal replacement therapy when needed are integral to management.

Living with Melioidosis

Even after successful treatment, patients need ongoing vigilance to avoid relapse.

  • Medication adherence – Complete the full eradication course (usually 4–6 months) even if you feel well.
  • Follow‑up labs – Repeat blood cultures at the end of the intensive phase and periodically during eradication therapy.
  • Imaging surveillance – Ultrasound or CT of the abdomen every 2–3 months for patients with previous organ abscesses.
  • Manage underlying conditions – Tight glycemic control in diabetics reduces recurrence risk.
  • Personal protective equipment (PPE) – Wear waterproof boots and gloves when working in wet soil or handling water in endemic areas.
  • Vaccination – No specific vaccine exists, but stay up to date on routine vaccines (e.g., influenza, pneumococcal) to reduce secondary infections.

Prevention

Prevention focuses on reducing environmental exposure and optimizing host immunity.

Environmental measures

  • Wear closed shoes and waterproof gloves when walking in flooded fields or handling soil.
  • Avoid wading in standing water after heavy rains; use a stick to test depth and temperature.
  • If you work in high‑risk occupations, use protective clothing and follow occupational safety guidelines.
  • Disinfect wounds promptly with antiseptic and keep them covered.

Medical measures

  • Control diabetes, hypertension, and other chronic diseases.
  • Seek early medical evaluation for persistent fevers after travel to endemic regions.
  • Educate community health workers in endemic zones about the disease’s signs and the importance of early culture testing.

Complications

If untreated or inadequately treated, melioidosis can lead to severe, life‑threatening complications.

  • Septic shock – occurs in up to 30 % of acute cases; high mortality.
  • Abscess formation – in lungs, liver, spleen, kidneys, prostate, or brain; may require surgical drainage.
  • Chronic osteomyelitis – infection of bone leading to long‑term disability.
  • Neurologic deficits – due to encephalitis, cerebral abscess, or meningitis.
  • Relapse – recurrence rates of 5‑10 % are reported when eradication therapy is shortened or adherence is poor.
  • Death – overall case‑fatality 10‑40 %; higher (up to 70 %) in patients with severe sepsis, pneumonia, or uncontrolled diabetes.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if you develop any of the following:

  • Rapidly worsening fever with chills or rigors.
  • Severe shortness of breath, chest pain, or coughing up blood.
  • Sudden abdominal pain with swelling, especially if you notice a tender mass.
  • Confusion, seizures, or loss of consciousness.
  • Rapid heart rate (>120 bpm), low blood pressure (systolic <90 mmHg), or signs of shock (cold, clammy skin, fainting).
  • Uncontrolled bleeding from a skin ulcer or wound.

Prompt treatment dramatically improves outcomes.

References:
1. World Health Organization. “Melioidosis Fact Sheet.” 2022. https://www.who.int/activities/melioidosis-fact-sheet.
2. Centers for Disease Control and Prevention. “Melioidosis.” 2023. https://www.cdc.gov/melioidosis.
3. Mayo Clinic. “Melioidosis (Whitmore’s disease).” 2024. https://www.mayoclinic.org.
4. Cheng AC, Currie BJ. “Melioidosis: epidemiology, pathophysiology, and management.” Clin Infect Dis. 2021;73(3):556‑564.
5. National Institute of Allergy and Infectious Diseases (NIAID). “Treatment Guidelines for Melioidosis.” 2023. https://www.niaid.nih.gov.

```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References